Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-28
DOI
10.1038/s41467-020-14906-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis
- (2019) Xiang Yu et al. Nature Communications
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
- (2018) Antoni Ribas et al. CELL
- Biomaterial-assisted targeted modulation of immune cells in cancer treatment
- (2018) Hua Wang et al. NATURE MATERIALS
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
- (2018) Zuqiang Liu et al. Nature Communications
- The Current State of Peptide Drug Discovery: Back to the Future?
- (2017) Antoine Henninot et al. JOURNAL OF MEDICINAL CHEMISTRY
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
- (2017) Manisha Singh et al. Nature Communications
- Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
- (2017) Zuqiang Liu et al. Nature Communications
- Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy
- (2016) Mingjun Liu et al. Journal of Translational Medicine
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+T cells
- (2016) Shu Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vivo Visualization of Tumor Antigen-containing Microparticles Generated in Fluorescent-protein-elicited Immunity
- (2016) Fei Yang et al. Theranostics
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity
- (2015) Natalie L. Trevaskis et al. NATURE REVIEWS DRUG DISCOVERY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- The role of lymph node sinus macrophages in host defense
- (2014) Mirela Kuka et al. Annals of the New York Academy of Sciences
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Hybrid Melittin Cytolytic Peptide-Driven Ultrasmall Lipid Nanoparticles Block Melanoma Growth in Vivo
- (2013) Chuan Huang et al. ACS Nano
- Melittin: A lytic peptide with anticancer properties
- (2013) Goran Gajski et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Bee Venom Phospholipase A2 Induces a Primary Type 2 Response that Is Dependent on the Receptor ST2 and Confers Protective Immunity
- (2013) Noah W. Palm et al. IMMUNITY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Engineering synthetic vaccines using cues from natural immunity
- (2013) Darrell J. Irvine et al. NATURE MATERIALS
- Role of the inflammasome in defense against venoms
- (2013) N. W. Palm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
- (2012) Jose Pulido et al. NATURE BIOTECHNOLOGY
- Whole Cell Vaccines—Past Progress and Future Strategies
- (2012) Bridget P. Keenan et al. SEMINARS IN ONCOLOGY
- Bee venom in cancer therapy
- (2011) Nada Oršolić CANCER AND METASTASIS REVIEWS
- Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
- (2009) Zhihong Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
- (2009) Neelesh R. Soman et al. JOURNAL OF CLINICAL INVESTIGATION
- Materials engineering for immunomodulation
- (2009) Jeffrey A. Hubbell et al. NATURE
- Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
- (2009) Manuel N. Melo et al. NATURE REVIEWS MICROBIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started